Our helpline will be

closed

on Tuesday 10 November 2026

Information

Information about neuroendocrine cancer

Explore clear, trusted information about neuroendocrine cancer, including the different types, possible causes, symptoms and treatment.

What is it?

Specialist care

Information events

Handbook and resources

Your cancer
How we can help

How we can help you and others.

Whether you’re living with neuroendocrine cancer or supporting someone who is, we’re here to help. Explore the information, practical guidance and emotional support available to you and those close to you.

Just diagnosed

Living with cancer

Practical matters

End of life matters

Family, friends and carers

Helpline

Support groups

Emotional support
Stories
Events
Support us

Your support is vital in helping us continue our work.

Whether you choose to fundraise, donate, volunteer or raise awareness, there are many ways to make a difference to people affected by neuroendocrine cancer.

Donate

Fundraise

Partner with us

Volunteer

Raise awareness

Shop
Research

Exploring neuroendocrine cancer research

Research is helping us better understand neuroendocrine cancer and improve how it is diagnosed and managed. Explore the latest developments and learn about research supported by Neuroendocrine Cancer UK.

About medical research

Interesting publications

Our research

Find a clinical trial
Contact
News
About us
Healthcare professionals
Donate

← Our News

General

Focusing on rarer cancers in Europe

By Neuroendocrine Cancer UK

Posted 10 years ago

08/05/2017 12pm

For more information on this new initiative, please click here EURACAN.

Catch up on the latest news, stories and updates

Successful UK liver transplant programme offers new hope for some people with neuroendocrine cancer

The UK and the Republic of Ireland run the only formal national programme for liver transplantation in patients with neuroendocrine tumours, and evidence shows those transplanted ...

Pancreatic Enzyme Replacement Therapy (PERT) Update

Ongoing variability in the supply of pancreatic enzyme replacement therapy (PERT) — particularly Creon® 25,000iu capsules — has left some people struggling to obtain their prescription. ...

Our helpline will be

closed

on Tuesday 10 November 2026

Information about neuroendocrine cancer

How we can help you and others.

Your support is vital in helping us continue our work.

Exploring neuroendocrine cancer research